These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 17700277)

  • 1. Contrast-enhanced magnetic resonance angiography: P792 blood pool agent versus Gd-DOTA in rabbits at 3.0 T versus 1.5 T.
    Herborn CU; Watkins DM; Baumann S; Robert P; Corot C; Runge VM
    Invest Radiol; 2007 Sep; 42(9):622-8. PubMed ID: 17700277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MR angiography with a new rapid-clearance blood pool agent: Initial experience in rabbits.
    Ruehm SG; Christina H; Violas X; Corot C; Debatin JF
    Magn Reson Med; 2002 Nov; 48(5):844-51. PubMed ID: 12417999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-enhanced magnetic resonance angiography: evaluation of the high relaxivity low diffusible gadolinium-based contrast agent P846 in comparison with gadoterate meglumine in rabbits at 1.5 Tesla and 3.0 Tesla.
    Peldschus K; Hamdorf M; Robert P; Port M; Graessner J; Adam G; Herborn CU
    Invest Radiol; 2008 Dec; 43(12):837-42. PubMed ID: 19002055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast-enhanced magnetic resonance angiography in rabbits: evaluation of the gadolinium-based agent p846 and the iron-based blood pool agent p904 in comparison with gadoterate meglumine.
    Kinner S; Maderwald S; Parohl N; Albert J; Corot C; Robert P; Barkhausen J; Vogt FM
    Invest Radiol; 2011 Aug; 46(8):524-9. PubMed ID: 21577130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MR diagnosis of a pulmonary embolism: comparison of P792 and Gd-DOTA for first-pass perfusion MRI and contrast-enhanced 3D MRA in a rabbit model.
    Keilholz SD; Bozlar U; Fujiwara N; Mata JF; Berr SS; Corot C; Hagspiel KD
    Korean J Radiol; 2009; 10(5):447-54. PubMed ID: 19721829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic Contrast-Enhanced MRI Using a Macromolecular MR Contrast Agent (P792): Evaluation of Antivascular Drug Effect in a Rabbit VX2 Liver Tumor Model.
    Park HS; Han JK; Lee JM; Kim YI; Woo S; Yoon JH; Choi JY; Choi BI
    Korean J Radiol; 2015; 16(5):1029-37. PubMed ID: 26357497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
    Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
    Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal functional contrast-enhanced magnetic resonance imaging: evaluation of a new rapid-clearance blood pool agent (p792) in sprague-dawley rats.
    Mandry D; Pedersen M; Odille F; Robert P; Corot C; Felblinger J; Grenier N; Claudon M
    Invest Radiol; 2005 May; 40(5):295-305. PubMed ID: 15829826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary magnetic resonance angiography: experimental evaluation of the new rapid clearance blood pool contrast medium P792.
    Taupitz M; Schnorr J; Wagner S; Kivelitz D; Rogalla P; Claassen G; Dewey M; Robert P; Corot C; Hamm B
    Magn Reson Med; 2001 Nov; 46(5):932-8. PubMed ID: 11675645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to compare the efficiency of albumin-bound and nonalbumin-bound contrast agents in vivo: the concept of dynamic relaxivity.
    Port M; Corot C; Violas X; Robert P; Raynal I; Gagneur G
    Invest Radiol; 2005 Sep; 40(9):565-73. PubMed ID: 16118549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the Contrast Enhancement Performance of Gadopiclenol for Magnetic Resonance Angiography in Healthy Rabbits and Pigs.
    Hugon G; Adriaensen H; Wintrebert M; Arnould L; Serfaty JM; Robert P
    Invest Radiol; 2024 Sep; 59(9):614-621. PubMed ID: 38709660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved evaluation of myocardial perfusion and viability with the magnetic resonance blood pool contrast agent p792 in a nonreperfused porcine infarction model.
    Peukert D; Kaufels N; Laule M; Schnorr J; Carme S; Farr T; Schönenberger E; Taupitz M; Hamm B; Dewey M
    Invest Radiol; 2007 Apr; 42(4):248-55. PubMed ID: 17351432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative dynamic contrast enhanced MRI of experimental synovitis in the rabbit knee: comparison of macromolecular blood pool agents vs. Gadolinium-DOTA.
    Watrin-Pinzano A; Loeuille D; Goebel JC; Lapicque F; Walter F; Robert P; Netter P; Corot C; Gillet P; Blum A
    Biomed Mater Eng; 2008; 18(4-5):261-72. PubMed ID: 19065032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extremely Small Pseudoparamagnetic Iron Oxide Nanoparticle as a Novel Blood Pool T1 Magnetic Resonance Contrast Agent for 3 T Whole-Heart Coronary Angiography in Canines: Comparison With Gadoterate Meglumine.
    Park EA; Lee W; So YH; Lee YS; Jeon BS; Choi KS; Kim EG; Myeong WJ
    Invest Radiol; 2017 Feb; 52(2):128-133. PubMed ID: 27977466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved vessel delineation in keyhole time-resolved contrast-enhanced MR angiography using a gadolinium doped flush.
    Beranek-Chiu J; Froehlich JM; Wentz KU; Doert AN; Zollikofer CL; Eckhardt BP
    J Magn Reson Imaging; 2009 May; 29(5):1147-53. PubMed ID: 19388120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of true-FISP sequence added to conventional gadolinium-enhanced MRA of abdominal aorta and its major branches.
    Iozzelli A; D'Orta G; Aliprandi A; Secchi F; Di Leo G; Sardanelli F
    Eur J Radiol; 2009 Dec; 72(3):489-93. PubMed ID: 18926654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-dimensional multiphase time-resolved low-dose contrast-enhanced magnetic resonance angiography using TWIST on a 32-channel coil at 3 T: a quantitative and qualitative comparison of a conventional gadolinium chelate with a high-relaxivity agent.
    Giesel FL; Runge V; Kirchin M; Mehndiratta A; Gerigk L; Corell B; von Gall C; Kauczor HU; Essig M
    J Comput Assist Tomogr; 2010; 34(5):678-83. PubMed ID: 20861769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crossover comparison of ferumoxytol and gadobenate dimeglumine for abdominal MR-angiography at 3.0 tesla: Effects of contrast bolus length and flip angle.
    Schubert T; Motosugi U; Kinner S; Colgan TJ; Sharma SD; Hetzel S; Wells S; Campo CA; Reeder SB
    J Magn Reson Imaging; 2017 Jun; 45(6):1617-1626. PubMed ID: 27862577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-pass and equilibrium-MRA of the aortoiliac region with a superparamagnetic iron oxide blood pool MR contrast agent (SH U 555 C): results of a human pilot study.
    Tombach B; Reimer P; Bremer C; Allkemper T; Engelhardt M; Mahler M; Ebert W; Heindel W
    NMR Biomed; 2004 Nov; 17(7):500-6. PubMed ID: 15523717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast-enhanced whole-heart coronary magnetic resonance angiography at 3.0 T: comparison with steady-state free precession technique at 1.5 T.
    Liu X; Bi X; Huang J; Jerecic R; Carr J; Li D
    Invest Radiol; 2008 Sep; 43(9):663-8. PubMed ID: 18708861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.